title: Achillea Millefolium L. Hydro- Alcoholic Extract Protects Pancreatic Cells by Down Regulating IL- 1β and iNOS Gene Expression in Diabetic Rats.
abstract: Interleukin-1β (IL-1β) has a role in β- cell destruction in autoimmune diabetes by stimulating the expression of inducible nitric oxide synthase (iNOS) that generates the free radical nitric oxide. We aimed to investigate the effect of Achillea millefolium L, as a traditional hypoglycemic agent, on IL-1β and iNOS gene expression of pancreatic tissue in the STZ- induced diabetic rats. Forty adult male Wistar rats were randomly divided into four groups: 1. diabetic control; 2. diabetic rats treated with Achillea millefolium L. extract; 3. normal rats received only extract and 4. negative control (n= 10 each). Diabetes was induced by single i.p. injection of 45 mg/ kg streptozotocin (STZ). Rats in groups 2 and 3 were treated with i.p. injection of Achillea millefolium L. extract (100 mg/ kg/ day) for 14 days. Body weight, serum glucose and insulin levels were assayed at baseline and on days 3, 7, 10 and 14 of the experiment. Finally, the quantity of pancreatic IL-1β and iNOS mRNA was determined by real- time PCR. The mRNA expression level of IL-1β and iNOS genes, was significantly (p<0.001) increased in diabetic rats of group 1. Treatment with Achillea millefolium L. caused a significant (p<0.01) reduction in both IL-1β and iNOS genes expression. Moreover, rats in group 2 had higher insulin level associated with lower glucose level and higher body weight compared to control diabetic group. It seems that beneficial effect of Achillea millefolium L. on STZ- induced diabetes is at least partly due to amelioration of IL-1β and iNOS gene over expression which can have a β-cell protective effect.
authors: Division of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
authors: Yalda
authors: Y
authors: Zolghadri
authors: Division of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
authors: Mehdi
authors: M
authors: Fazeli
authors: Division of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
authors: Marzieh
authors: M
authors: Kooshki
authors: Division of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
authors: Tahoora
authors: T
authors: Shomali
authors: Division of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
authors: Negar
authors: N
authors: Karimaghayee
authors: Division of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
authors: Maryam
authors: M
authors: Dehghani
keywords: Achillea millefolium L.; IL-1β; diabetes; gene expression; iNOS
references: Nat Rev Endocrinol. 2009 Jun;5(6):305-11
references: 19399017
references: Pediatr Res. 2012 Jun;71(6):626-32
references: 22337228
references: Biochem Pharmacol. 1998 Apr 15;55(8):1139-49
references: 9719467
references: J Clin Invest. 1998 Aug 1;102(3):516-26
references: 9691088
references: J Exp Med. 1995 Feb 1;181(2):559-68
references: 7530759
references: J Biochem Mol Toxicol. 2003;17(1):24-38
references: 12616644
references: World J Gastroenterol. 2010 Jul 14;16(26):3249-57
references: 20614480
references: J Vector Borne Dis. 2008 Dec;45(4):301-6
references: 19248657
references: Cardiovasc Diabetol. 2005 Apr 29;4:5
references: 15862133
references: Lancet. 2001 Jul 21;358(9277):221-9
references: 11476858
references: Diabetes Metab Res Rev. 2001 May-Jun;17(3):189-212
references: 11424232
references: J Diabetes Metab Disord. 2013 Jul 08;12(1):39
references: 23834750
references: J Ethnopharmacol. 2002 Oct;82(2-3):197-205
references: 12241996
references: Diabetes Care. 1989 Sep;12(8):553-64
references: 2673695
references: Int J Mol Sci. 2013 Jun 24;14(7):12978-93
references: 23797659
references: Diabetes. 1999 Sep;48(9):1730-6
references: 10480601
references: Cancer Treat Rep. 1982 Mar;66(3):427-38
references: 6277485
references: Diabetologia. 2001 Dec;44(12):2115-33
references: 11793013
references: Biol Pharm Bull. 2005 Sep;28(9):1791-4
references: 16141563
references: PLoS Med. 2006 Feb;3(2):e17
references: 16354107
references: Biochem J. 1987 Jul 1;245(1):243-50
references: 3117042
references: Physiol Res. 2001;50(6):537-46
references: 11829314
references: Mol Pharmacol. 2007 Dec;72(6):1657-64
references: 17895408
references: J Ethnopharmacol. 2001 May;75(2-3):181-4
references: 11297848
references: Diabetologia. 2007 Mar;50(3):602-11
references: 17221214
references: Nutrition. 2002 Oct;18(10):872-9
references: 12361782
references: Diabetes. 2001 Mar;50(3):551-7
references: 11246874
references: Ann N Y Acad Sci. 2005 Jun;1043:440-51
references: 16037265
references: Minerva Endocrinol. 2011 Jun;36(2):147-56
references: 21519323
references: Diabetes. 2003 Mar;52(3):621-33
references: 12606501
references: Indian J Exp Biol. 2002 Jan;40(1):31-4
references: 12561964
references: J Cell Mol Med. 2008 Apr;12(2):591-606
references: 18081694
references: Biotechniques. 2002 Jun;32(6):1372-4, 1376, 1378-9
references: 12074169
references: Diabetes Res Clin Pract. 2002 Jan;55(1):65-85
references: 11755481
references: Diabetologia. 1976 May;12(2):123-8
references: 131726
references: J Clin Invest. 2002 Sep;110(6):851-60
references: 12235117
references: Physiol Res. 2000;49 Suppl 1:S37-42
references: 10984070